Edward Lanphier,
CEO
Edward Lanphier is the founder of Sangamo BioSciences, and has served as president, chief executive officer and a member of the Board of Directors since the company’s inception in 1995. He has over 30 years of experience in the pharmaceutical and biotechnology industry including senior management positions at Somatix Therapy Corporation, BioGrowth, Inc., Biotherapeutics, Inc., and Synergen, Inc. Before joining Synergen, he was employed by Eli Lilly and Company in the strategic business planning-biotechnology group. Mr. Lanphier is currently the Chairman of the Board and Executive Committee of the Alliance for Regenerative Medicine, the preeminent global advocate for regenerative and advanced therapies. He also serves on the Board of Directors of The Biotechnology Institute, the Board of Trustees of The Buck Institute for Research on Aging, is a member of the Industry Advisory Board for the California Institute for Regenerative Medicine, and is on the Dean’s Advisory Board of the University of Michigan School of Public Health. Mr. Lanphier has a B.A. in biochemistry from Knox College.
|
.png)
|
|
